Award
Delivery Order #SPE2DR26F9S8F
Delivery Order for Novolog Insulin Pens to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$4,741.24
Ceiling
$4,741.24
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26F9S8F
NAICS
424210
This award represents a delivery order contract issued under an existing indefinite delivery vehicle held by AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company serving health systems and pharmaceutical clients. The contract procures a specified quantity of Novolog 100 unit/ml FlexPen 3ml insulin pens, a crucial pharmaceutical product used in managing diabetes, thus supporting essential healthcare delivery. The scope of work includes the timely provision and delivery of these insulin pens to the designated location in Conshohocken, Pennsylvania, within a short window of performance. This order is part of a broader pharmaceutical supply agreement, demonstrating AmerisourceBergen's ongoing commitment and significant role in ensuring the continuous availability of vital medications to government health services. The contract was awarded as a follow-on delivery order to a parent indefinite delivery contract, indicating a non-competitive procurement consistent with previously established terms and vendor selection. The short-term timeline highlights the immediate procurement needs addressed by this contract to maintain uninterrupted patient care.
Description
4571087296!NOVOLOG 100 UNIT/ML FLEXPEN 3ML